The Impact of Phase I Cardiac Rehabilitation on the Prognosis of AMI Patients After PCI

NCT ID: NCT06406218

Last Updated: 2024-05-09

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 1100 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-04-24
• Study Completion Date: 2026-04-30

Brief Summary

Previous research has confirmed that patients undergoing percutaneous coronary intervention (PCI) can benefit from cardiac rehabilitation programs. However, there is a paucity of studies on Phase I cardiac rehabilitation commenced within three days following PCI in patients with acute myocardial infarction (AMI). Consequently, the objective of the study is to demonstrate whether Phase I cardiac rehabilitation can improve the prognosis at 12 months when compared with the control group. The primary endpoint is the Seattle Angina Questionnaire (SAQ) score at 12 months for the patients. The principal hypothesis of the study is that Phase I cardiac rehabilitation will improve the long-term prognosis for AMI patients at 12 months after PCI.

Conditions

Acute Myocardial Infarction; Phase I Cardiac Rehabilitation

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

Phase I Cardiac Rehabilitation Exercise Training

Group Type: EXPERIMENTAL

Phase I Cardiac Rehabilitation Exercise Training

Intervention Type: BEHAVIORAL

A) In the morning, take a supine position and perform straight leg raises with each leg individually, lifting to a height of 30° and holding for 3-5 seconds. Raise both arms to the side of the head to a 90° angle and hold for 5-10 seconds. Inhale deeply when exerting force and exhale slowly when lowering. Alternate between leg lifts and arm raises, performing 5 sets per session. Adjust intensity based on individual condition and may be repeated. In the afternoon, sit beside the bed for 5 minutes. B) After transitioning to secondary care according to the patient's condition, stand beside the bed for 5 minutes in the morning; in the afternoon, march in place beside the bed for 5 minutes. C) Walk beside the bed for 10 minutes per session, twice a day. D) Move around and doing activities under supervision inside the ward, 10 minutes per session, twice a day.

Spend approximately one day at each level, gradually progressing the exercise to the patient's tolerance level.

Guideline control

During hospitalization, patients assigned to the guideline control only receive routine medication treatment according to the guidelines, without any exercise intervention or education.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Phase I Cardiac Rehabilitation Exercise Training

A) In the morning, take a supine position and perform straight leg raises with each leg individually, lifting to a height of 30° and holding for 3-5 seconds. Raise both arms to the side of the head to a 90° angle and hold for 5-10 seconds. Inhale deeply when exerting force and exhale slowly when lowering. Alternate between leg lifts and arm raises, performing 5 sets per session. Adjust intensity based on individual condition and may be repeated. In the afternoon, sit beside the bed for 5 minutes. B) After transitioning to secondary care according to the patient's condition, stand beside the bed for 5 minutes in the morning; in the afternoon, march in place beside the bed for 5 minutes. C) Walk beside the bed for 10 minutes per session, twice a day. D) Move around and doing activities under supervision inside the ward, 10 minutes per session, twice a day.

Spend approximately one day at each level, gradually progressing the exercise to the patient's tolerance level.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

1. Patients with AMI (including STEMI and NSTEMI) who were treated in the CCU (Coronary Care Unit) for more than 12 hours after emergency PCI;

2. Patients who are expected to meet the discharge criteria without the need for repeat PCI during the current hospital stay after PCI;

3. No chest pain episodes within 8 hours, with no recurrence of myocardial infarction; remained hemodynamically stable;

4. No further increase in serum levels of cardiac biomarkers such as Creatine Kinase -MB (CK-MB) and cardiac troponins (cTn).

Exclusion Criteria

1. Patients with Killip class III or higher, or symptoms and signs of acute pulmonary edema and respiratory distress;

2. Malignant arrhythmias that cause hemodynamic instability and potentially life-threatening conditions;

3. Mechanical lesions such as ventricular wall rupture, valve or tendon rupture;

4. Patients who have not yet been weaned off ECMO, IABP, temporary pacemakers, CRRT;

5. Patients with liver or kidney dysfunction (transaminase exceeded three times the upper limit of normal; EGFR<30 ml/(min·1.73m^2)) or advanced malignant tumors;

6. Patients who cannot undergo exercise rehabilitation due to orthopedic or psychiatric diseases;

7. Patients with language impairment;

8. Patients currently undergoing systematic training or participating in other clinical trials without reaching the primary endpoint collection time;

9. Researchers believe that patients are not suitable for participation in this study or have not obtained an informed consent form.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Han Yaling, MD

OTHER

Sponsor Role: lead

Responsible Party

Han Yaling, MD

Chief Physician

Responsibility Role: SPONSOR_INVESTIGATOR

Principal Investigators

Ya-Ling Han, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Cardiology, General Hospital of Northern Theater Command, Shenyang 110016, China

Locations

General Hospital of Northern Theater Command

Shenyang, Liaoning, China

Site Status: RECRUITING

Countries

China

Central Contacts

Ya-Ling Han, PhD

Role: CONTACT

hanyaling@263.net

+86 024-28897309

Facility Contacts

Ya-Ling Han, PhD

Role: primary

hanyaling@263.net

+86 024-28897309

Other Identifiers

AID

Identifier Type: -

Identifier Source: org_study_id